Buprenorphine vs Pembrolizumab

## Buprenorphine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Buprenorphine** and **Pembrolizumab**.

## Mechanism of Action

**Buprenorphine**: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Buprenorphine — 24-42 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Buprenorphine — C29H41NO4; Pembrolizumab — N/A.

**Molecular Weight**: Buprenorphine — 467.6430 g/mol; Pembrolizumab — N/A.

**Type**: Buprenorphine — Small molecule; Pembrolizumab — Antibody.